Elisa and Rapid Test for SARS-CoV 2 serology
Both evaluated by French National Reference Center and 2 University Hospitals, serological kits were developed on antigen based on Protein S.
Their performances were demonstrated on several cohorts of patients and all report their diagnostic effectiveness.
Efficient ELISA tests
In accordance with French HAS (High Health Authority) recommendations, Theradiag offers you to carry out IgG and IgM assays directed against SARS CoV-2.
These ELISA kits did not show cross-reactions with coronavirus usually encountered (OC43, C229E, NL63, HKU1) or with other respiratory pathogens such as Influenza A/B, Legionella Pneumophila, C.Pneumoniae, M.Pneumonia, Haemophilus influenzae.
Our IgG Assay offers a quantitative approach of Ig levels.
Based on this cohort and compared with molecular method, results show a sensitivity and specificity of 100% for IgG.
Elisa Covid-9 THERA02 IgG
Our IgM kit integrates a specific absorbent for IgGs
Based on this cohort and compared with molecular method, results show a sensitivity and specificity of 99% for IgM.
Elisa Covid-9 THERA02 IgM
A reliable Rapid Test
Based on an immunochromatography approach, the TDR Covid-19 IgG+IgM THERA brings you a reliable information in 15 minutes on whole blood, plasma or serum.
Based on this cohort, it shows a specificity of 100% and sensitivity of 93%
|TDR Covid-19 IgG+IgM THERA||Positive||Negative||Total|